Over 20 years of experience in R&D

01 Drug Discovery

Chemistry Research

Biology Research

Early Pharmacokinetics

02 Pharmaceutical Research

Intermediates

Active Pharmaceutical Ingredients

Pharmaceutical preparation

Analytical Method Development and Quality Control

CMC Filings

Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics

Drug Safety Evaluation

DMPK

Bioanalysis

IND Filings

01 One-stop Integrated Services

Liposome Drug Development

Drug Discovery

Pharmaceutical Research

Preclinical Research

Botanical Drug Preclinical R&D

02 Innovative Drug Services

ADC

PROTAC

mRNA Vaccine

Cellular Immunotherapies

Nucleic Acid Drug

Peptide Drug Conjugate (PDC)

Antibody

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection

Metabolite Identification (MetID)

Drug Forming Research

Flow Cytometry Technology

SEND Format Conversion

Flow Sorting

NanoString nCounter Detection

Routes of Drug Administration

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model

Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease

05 Advanced Preparation R&D

Inhalation drug

Ophthalmic drug

Skin Topical Preparation

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service

GLP-1 New Drug R&D Service

KRAS-targeted Drugs R&D Service

2024-09-13Medicilon Events

Medicilon Non-tumor Pharmacology Service Platform

Medicilon boasts 260+ evaluation models for non-tumor diseases, covering the inflammatory & immune diseases, CNS diseases, digestive diseases, , Metabolic diseases, cardiovascular diseases and other diseases.

Learn more

2024-08-29Medicilon Events

Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts

In August 2024, Medicilon USA Corp (Medicilon)officially commenced operations at its second R&D center in Massachusetts, USA.

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER

Intellectual Property Protection

U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Shanghai Public Network Security File No. 31011502018888 | Website Map

Drug Discovery

FAQs

HomeservicesDrug DiscoveryBiology ResearchStructural BiologySelenomethionine Medium

Selenomethionine Medium

Medicilon provides complete sets of M9 selenomethionine (SeMET) medium for the IPTG-induced E. coli expression system, enabling the production of selenomethionine-labeled proteins and protein crystallography using multi-wavelength anomalous diffraction (MAD). This medium simplifies E. coli culture steps and reduces time, manpower, and material costs.

Services

Selenomethionine (SeMET) Medium
With our optimization, the Structural Genome Laboratory can accelerate protein production. We can also design and optimize the culture medium based on your needs. The medium's components do not require sterilization or weighing; they are added sequentially following the attached instruction manual. The M9 high-yield medium doubles bacterial yield and is widely used in scientific research and the biomedical industry.

M9 SeMET High-yield Growth Media Kit Packages

Packages	Catalog #	Price ($)
M9 SeMET high-yield media,packaged for growing 12X1 liter culture.	MD045004-12L	400/set
M9 SeMET high-yield media,packaged for growing 50X1 liter culture.	MD045004-50L	1500/set

Amino Acid Deficient Medium (for insect cell culture)
We can provide a series of amino acid-deficient media, including methionine-deficient and phenylalanine-deficient options, for labeling and studying the structure of recombinant proteins. These media are liquid serum-free mediums, and the corresponding amino acids are removed from the basic medium of insect cells as required.